Teva Halts Phase III Trial of Fremanezumab in Chronic Cluster Headaches
Teva tries to make something out of nothing with Ajovy approval | Evaluate
Teva's recalled migraine medicine Zecuity has a long local history - Philadelphia Business Journal
Report: Teva Suffers Migraine Over Express Scripts Drug Exclusion - Pharmaceutical Processing World
Jennifer Morrison featured in Teva migraine awareness campaign. - Philadelphia Business Journal
Teva Pharmaceuticals on Twitter: "Meet our #migraine expert, Dr Joshua Cohen, as he shares his own story of living with #migraine and explains the impact the disease can have on patients. Read
Teva's migraine med given marketing authorization
Teva Canada Announces Product Availability of AJOVY™ | Business Wire
Teva Wins Three, Loses Six in Patent Battle Over Migraine Drug – PharmaLive
FDA approves Vyepti, first IV preventive treatment for migraine
Teva tackles migraine through potential $400m Heptares collaboration
Xconomy: Teva Migraine Drug Likely Delayed by Manufacturing Trouble
FDA approves Teva's migraine injection AJOVY™ - Pf Media
Ajovy Now Available in Autoinjector Device for Migraine Prevention - MPR
Ajovy, Teva's migraine drug, recommended by UK's NICE.
Teva's migraine drug Ajovy looks set for EU approval -
Ajovy™ Approved by FDA for Migraine Prevention in Adults
No joy for Ajovy: Teva's migraine drug can't find a convincing win in meta-analysis versus Biohaven, AbbVie meds | Fierce Pharma
Boston Jury Awards Teva Pharmaceuticals $176.5M for Eli Lilly's Migraine Medication Patent Infringement | Law.com
AbbVie, Biohaven, Teva and Satsuma tackle migraine at AHS – PharmaLive
Eli Lilly (NYSE:LLY) Loses Migraine Drug Patent Trial to Teva
Fed Circ. upholds some Teva migraine drug patents, invalidates others | Reuters
With clock ticking on Teva migraine drug, analyst expresses doubt for approval | Fierce Pharma
Teva to suspend sales of Zecuity migraine patch
Teva launches AJOVY for the treatment of migraine with the YpsoMate autoinjector from Ypsomed - Ypsomed - Group
Teva Canada Announces New Autoinjector for AJOVY® for the Preventive Treatment of Migraine in Adults | Business Wire
Beyond Migraine
Teva migraine medicine gets EU positive opinion
